K-ASMAL KETOTIFENO 1 mg 30 Tabs MEXICO
KETOTIFEN (Systemic) Some typically used brand names are: In Canada— * Apo-Ketotifen * Novo-Ketotifen * K-ASMAL Description Ketotifen (kee-toe-TYE-fen) is a sort of asthma pharmaceutical which, when taken reliably and used close by other antiasthma meds, may diminish the repeat, earnestness, and compass of asthma symptoms or attacks in young people.
It may in like manner provoke a diminishment in consistently necessities of other antiasthma pharmaceuticals. Ketotifen is not convincing for the expectation or treatment of extreme asthma attacks. Ketotifen satisfies desires via controlling certain substances in the body that are known to cause irritation and evidences of asthma.
K-ASMAL KETOTIFENO fumarate
K-ASMAL KETOTIFENO fumarate is almost completely absorbed from the gastrointestinal tract after oral doses, but bioavailability is reported to be only about 50% due to hepatic first-pass metabolism. Peak plasma concentrations occur 2 to 4 hours after an oral dose. It is mainly excreted in the urine as inactive metabolites with a small amount of unchanged drug; the terminal elimination half-life is about 21 hours.
K-ASMAL KETOTIFENO is antihistamine
K-ASMAL KETOTIFENO is a sedating antihistamine that also has a stabilising action on mast cells analogous to that of sodium cromoglicate. It is used in the treatment of allergic conditions such as rhinitis and conjunctivitis. Ketotifen has also been used in the prophylactic management of asthma, when it may take several weeks to exert its full effect; it should not be used to treat acute asthma attacks.
K-ASMAL KETOTIFENO oral doses
K-ASMAL KETOTIFENO is given as the fumarate, but doses are expressed in terms of the base; ketotifen fumarate 1.38 mg is equivalent to about 1 mg of ketotifen. Ketotifen fumarate is taken in oral doses equivalent to 1 mg of ketotifen twice daily with food, increased if necessary to 2 mg twice daily; 0.5 to 1 mg at night may be preferable for the first few days of treatment if drowsiness is likely to be a problem. Ketotifen fumarate has also been applied topically, as eye drops equivalent to 0.025% ketotifen, used twice daily. For children’s doses, see below.
K-ASMAL KETOTIFENO children’s dose
K-ASMAL KETOTIFENO fumarate can be given to children for the treatment of allergic conditions such as rhinitis or conjunctivitis, and has been used in the prophylactic management of asthma. Oral doses equivalent to 1 mg of ketotifen twice daily with food may be used from 3 years of age. A dose equivalent to 500 micrograms ketotifen twice daily has been suggested in children between 6 months and 3 years of age. Ketotifen fumarate has also been applied topically twice daily, as eye drops equivalent to 0.025% ketotifen, in children from 3 years of age.
